Showing results (1931-1940 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|February 9, 2019
Plasma fibrinogen levels correlate with prognosis and treatment outcome in patients with non-M3 acute myeloid leukemiaKanchun Dai, Qianying Zhang, Yingying Li, et al.
Leukemia & Lymphoma|January 15, 2019
Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndromeFlorian Anzengruber, Desislava Ignatova, Tanja Schlaepfer, et al.
Leukemia & Lymphoma|January 16, 2019
Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantationDeborah Christen, Kristina Sohlbach, Stephan K Metzelder, et al.
Leukemia & Lymphoma|January 17, 2019
A comprehensive catalog of LncRNAs expressed in T-cell acute lymphoblastic leukemiaYasmina Kermezli, Wiam Saadi, Mohamed Belhocine, et al.
Leukemia & Lymphoma|January 17, 2019
Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphomaKathryn S Nevel, Elena Pentsova, Mariza Daras
Leukemia & Lymphoma|January 29, 2019
The prognostic role of end of treatment FDG-PET-CT in patients with diffuse large B cell lymphoma can be improved by considering it with absolute monocyte count at diagnosisRaffaella Marcheselli, Antonella Franceschetto, Stefano Sacchi, et al.
Leukemia & Lymphoma|September 28, 2020
Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapyMaciej Tatarczuch, Erin Paul, Michael Gilberston, et al.
Leukemia & Lymphoma|September 14, 2020
The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitorMohammad Eskandari, Yang Shi, John Liu, et al.
Leukemia & Lymphoma|September 28, 2020
Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemiaRyan J Daley, Sridevi Rajeeve, Charlene C Kabel, et al.
Leukemia & Lymphoma|September 11, 2020
Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†Mengyang Di, Orestis A Panagiotou, John L Reagan, et al.
Pageof 1,001